Crexont kept symptoms at bay for an extra 30 minutes a day when compared with other Parkinson’s drugs. Amneal Pharmaceuticals Inc. announced yesterday the FDA approval for Parkinson’s drug Crexont (carbidopa and levodopa) via a news release on their website. This novel medication, formerly known as IPX203, combines two common drugs into one capsule.

FDA Approval Granted for Novel Parkinson’s Treatment

Inspire Medical Systems, a medical technology company focused on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced the FDA approval of the Inspire V therapy system which includes the next generation neurostimulator and the associated Bluetooth patient remote and physician programmer. Inspire...

FDA Approves 'Mask-Free' Sleep Apnea Treatment Device

Ascendis Pharma should be well prepared for the U.S. launch of its hormone replacement therapy for hypoparathyroidism, which was approved on Friday by the FDA. After all, the company was initially set to bring the drug to the market 15 months ago before the FDA rejected it with a surprise complete response letter (CRL). Then three months ago, Ascendis again was ready to roll before the U.S. regulator said it needed an additional three months to make its decision.

Ascendis scores hard-fought FDA nod for hormone replacement therapy Yorvipath

The FDA on Monday approved Ascendis Pharma’s palopegteriparatide, which was developed as TransCon PTH, for the treatment of adults with the rare endocrine disorder hypoparathyroidism. The drug will be marketed under the brand name Yorvipath. The company is currently wrapping up the manufacturing of Yorvipath and expects the product...

Ascendis’ Hypoparathyrodism Drug Secures FDA Approval Following Tough Regulatory Path

In this interview, Kim speaks about the significance of the FDA approval of neffy for patients who face the threat of anaphylaxis and other severe allergic reactions. The US Food and Drug Administration (FDA) approved an epinephrine nasal spray formulated for emergency treatment of adults and children with severe allergic reactions like anaphylaxis. This treatment, the first non-injectable option for severe allergic reactions, is known as ‘neffy.’1.

Impact of Nasal Epinephrine Spray for Patients with Severe Allergies, with Edwin H. Kim, MD

Topamax (topiramate) is a brand-name drug that’s prescribed to help prevent migraine headaches. This article covers topics such as side effects, dosage, and how Topamax works. Topamax is available in these forms: oral tablets and sprinkle capsules. Topamax belongs to a drug class called anticonvulsants. The medication is available...

Topamax for migraine

ARS Pharmaceuticals (Nasdaq:SRPY) announced that it received FDA approval for its neffy (epinephrine nasal spray) 2 mg for treating of Type I allergic reactions. Approval includes the treatment of anaphylaxis, with the indication covering adults and children who weigh ≥30 kg (66 lbs.). It marks a major innovation in epinephrine delivery as the first and only needle-free treatment option for people with severe allergic reactions. neffy could provide an alternative to the popular EpiPen option that utilizes a needle.

ARS Pharmaceuticals wins first FDA approval for needle-free, nasal epinephrine

Savannah, GA

Contributors represent independent, third-party users who have joined our contributor program and self-verified their accounts. They have also demonstrated their experience writing hard news for other outlets. Contributors are expected, like all users, to adhere to our Community Standards.

contributor

Daily Coffee Press

Newly returned indictments in the Southern District of Georgia include felony charges for illegal firearms possession and drug distribution, while additional defendants have been sentenced to federal prison or await further proceedings after pleading guilty to federal gun charges.

Federal Charges in Southern GA: Indictments and Sentences for Firearms and Drug Offenses

Acute kidney injury (AKI) is one of the most frequent complications of cardiac surgery and the cause is complex. Renal hypoperfusion from decreased glomerular filtration rate after cardiopulmonary bypass is a major contributor. 1 This in combination with exogenous toxins, endogenous metabolites, oxidative stress, bleeding and reperfusion injury can all...

The PROTECTION Trial – A Randomized Trial of Intravenous Amino Acids for Kidney Protection

Everyday Health

Hypoglycemia symptoms include having anxiety, emotional instability, dizziness, and lightheadedness. Here's a list with more signs to watch for.

10 Warning Signs of Low Blood Sugar

Learn about eosinophilic esophagitis (EoE) and its symptoms, including chronic cough, treatment options, and diagnosis methods.

Can Eosinophilic Esophagitis Be the Reason Behind Your Chronic Cough?

Georgia State

Appling County, GA

A 40-year-old man from Appling County, Christopher Eric Stone, with a significant criminal history, was recently sentenced to over five years in prison after pleading guilty to possession of methamphetamine with intent to distribute, according to officials from the Department of Justice.

Georgia Man Sentenced to Over 5 Years for in Federal Prison for Meth Distribution

A phase 2 study found that a combination of pacritinib, sirolimus, and tacrolimus successfully suppressed pSTAT3 and Th1/Th17 cells, but failed to prevent acute graft-versus-host disease following allogeneic transplant. A prophylactic regimen of pacritinib (Vonjo), sirolimus (Rapamune), and tacrolimus (Prograf) suppressed pSTAT3 and Th1/Th17 cells, but did not effectively prevent...

Pacritinib, Sirolimus, and Tacrolimus Combo Fails to Improve GVHD Outcomes

The researchers concluded that "combining canaloplasty with cataract surgery does not compromise the efficacy or safety of the former and might provide a higher absolute IOP reduction and reduced medication burden." Photo: James L. Fanelli, OD. Click image to enlarge. Most studies of canaloplasty efficacy limit their follow-up periods to...

Canaloplasty Provides Long-term IOP Reduction for Glaucoma Patients

Many consumers are familiar with EpiPens and other epinephrine injectables when treating severe allergic reactions. Now, the Food and Drug Administration (FDA) has approved the first non-injectable treatment for anaphylaxis, a nasal spray dubbed “neffy.”. “Today’s approval provides the first epinephrine product for the treatment of anaphylaxis that is...

FDA approves first nasal spray for serious allergic reactions

Massachusetts State

Writers represent independent, third-party users who have joined our contributor program and self-verified their accounts. Writers are expected, like all users, to adhere to our Community Standards.

writer

Dianna Carney

Sandy Paws Rescue Inc., a foster-based rescue organization in Massachusetts, recently shared their furry friends who have been waiting the longest to find their forever homes. From a puppy who is housebroken and loves toys to a little five-year-old dog who is a great snuggle buddy and loves other dogs, each dog is unique but has one thing in common- they need a family who will love them. Get to know these five great dogs below, and don't forget to leave a comment to let me know which pup stole your heart!

Local Animal Rescue Shares Dogs Who've Been Looking For Love The Longest

Humacyte on Friday announced that the FDA will need more time to review its investigational acellular tissue engineered vessel, which the company is proposing for the treatment of vascular trauma. The regulator was initially scheduled to release its verdict by Aug. 10. The FDA—which informed Humacyte of the delay on...

FDA Needs More Time to Review Humacyte’s Blood Vessel Implant

In a recent study, the investigational drug, PIPE-307, effectively induced OPC differentiation and remyelination in MS donor human brain tissue and an animal model and restored lost function in an MS mouse model. Multiple sclerosis (MS) is an autoimmune disease in which aberrant inflammatory processes cause destruction of the protective...

Potential First-in-Class M1R Antagonist May Promote Remyelination and Restore Function in Patients with MS

Projections from an agent-based model based on data from Ontario, Canada, suggest both current and prospective strategies may not meet World Health Organization HCV goals. Current prevention, screening, and treatment strategies will not be sufficient to fully meet the World Health Organization (WHO) goals for reducing hepatitis C virus (HCV) incidence and deaths, according to findings from a recent study.1.

Current HCV Screening, Treatment Strategies Projected to Fall Short of WHO Goals

Newark, NJ

Morristown Minute

NEWARK, N.J. – An Essex County man has been charged with numerous offenses related to narcotics distribution and firearms trafficking. Kyrell Domnie, 39, of Irvington, known by the alias "Fly Ky," was charged by complaint and appeared before U.S. Magistrate Judge Cathy L. Waldor in Newark federal court on July 17, 2024. He remains detained following the hearing.

Convicted Felon Faces Multiple Narcotics and Firearms Charges

NewsBreak

FDA Approves Palopegteriparatide for Hypoparathyroidism

Palopegteriparatide’s approval was based on positive data from the global Phase 2 PaTH Forward and Phase 3 PaTHway trials. The US Food and Drug Administration (FDA)...

FDA Approves Palopegteriparatide for Hypoparathyroidism

Comments / 0